Bioequivalence of Topical Acyclovir in Healthy Volunteers

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Dermatologic Disorders
Interventions
DRUG

5% Zovirax® cream

(manufactured by GlaxoSmithKline Pharma in Canada, distributed in the USA by Valeant Pharmaceuticals North America LCC, Bridgewater,NJ 08807)

DRUG

5% Aciclostad cream

(STADA Arzneimittel GmbH, Vienna, Austria)

DRUG

5% Aciclovir cream 1A Pharma

(1A Pharma GmbH, Vienna, Austria)

DRUG

5% Zovirax Cold Sore Cream

(GlaxoSmithKline Consumer Health Care, Brendfort, UK; Marketing authorization holder: Beeham Group PLC, Brendfort, UK)

DRUG

5% Zovirax® cream (Austria)

(GlaxoSmithKline Pharma GmbH, Vienna, Austria)

PROCEDURE

OFM

Sampling method for interstitial fluid

DEVICE

OFM Probe

Sampling probe used during OFM

DEVICE

OFM Pump

Pump used to operate OFM probes

Trial Locations (1)

8036

Medical University Graz, Graz

All Listed Sponsors
collaborator

Joanneum Research Forschungsgesellschaft mbH

OTHER

lead

Medical University of Graz

OTHER

NCT02711267 - Bioequivalence of Topical Acyclovir in Healthy Volunteers | Biotech Hunter | Biotech Hunter